Recommendations for Prevention and Control of Influenza
Journal: Annals of Internal Medicine (1986)

Diagnosis and Treatment1 September 1986Recommendations for Prevention and Control of InfluenzaRecommendations of the Immunization Practices Advisory CommitteeAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-105-3-399 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail AbstractThese recommendations of the Immunization Practices Advisory Committee update for 1986-1987 the information on the vaccine and antiviral agent available for control of influenza. Changes include addition of statements about: updating of the influenza strains in the vaccine for 1986-1987; immunization and amantadine prophylaxis for household members who provide home care for high-risk persons; optimal time for conducting routine vaccination programs; concurrent administration of influenza vaccine and childhood vaccines; immunization of children receiving long-term aspirin therapy; and other sources of information about influenza and control measures.Selected Bibliography1. ARDENPATRIARCAKENDAL NPA. Experiences in the use and efficacy of inactivated influenza vaccine in nursing homes. In: KENDAL AP, PATRIARCA PA, eds. Options for the control of influenza. New York: Alan R. Liss; 1986; 155-68. Google Scholar2. BARKER W. Excess pneumonia and influenza associated hospitalization during influenza A epidemics in the U.S., 1970-78. In: KENDAL AP, PATRIARCA PA, eds. Options for the control of influenza. New York: Alan R. Liss; 1986; 75-87. Google Scholar3. BARKERMULLOOLY WJ. Effectiveness of inactivated influenza vaccine among non-institutionalized elderly persons. In: KENDAL AP, PATRIARCA PA, eds. Options for the control of influenza. New York: Alan R. Liss; 1986; 169-82. Google Scholar4. BARKERMULLOOLY WJ. Influenza vaccination of elderly persons: reduction in pneumonia and influenza hospitalizations and deaths. JAMA. 1980;244:2547-9. CrossrefMedlineGoogle Scholar5. BARKERMULLOOLY WJ. Impact of epidemic type A influenza in a defined adult population. Am J Epidemiol. 1980;112:798-811. CrossrefMedlineGoogle Scholar6. BARKERMULLOOLY WJ. Pneumonia and influenza deaths during epidemics: implications for prevention. Arch Intern Med. 1982; 142:859. CrossrefGoogle Scholar7. BUKOWSKYJMUNTWIGLENAKATSU MPRK. Theophylline clearance. Lack of effect of influenza vaccination and ascorbic acid. Am Rev Respir Dis. 1984;129:672-5. CrossrefMedlineGoogle Scholar8. . Amantadine: does it have a role in prevention and treatment of influenza?: a National Institutes of Health Consensus Development Conference. Ann Intern Med. 1980;92:256-8. LinkGoogle Scholar9. DESTEFANOGOODMANNOBLEMCCLARYSMITHBROOME FRGGSC. Simultaneous administration of influenza and pneumococcal vaccines. JAMA. 1982;247:2551-4. CrossrefGoogle Scholar10. DOLINREICHMANMADOREMAYNARDLINTONWEBBER-JONES RRHRPJ. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med. 1982;307:580-4. CrossrefMedlineGoogle Scholar11. DOWDLECOLEMANGREGG WMM. Natural history of influenza type A in the United States, 1957-1972. Prog Med Virol. 1974;17:91135. Google Scholar12. EICKHOFF T. Immunization against influenza: rationale and recommendations. J Infect Dis. 1971; 123:446-54. CrossrefMedlineGoogle Scholar13. FEDSONKESSLER DH. A hospital-based influenza immunization program, 1977-78. Am J Public Health. 1983;73:442-5. CrossrefMedlineGoogle Scholar14. GALASSOTYERYARCATE GFT, eds. Clinical studies of influenza vaccines—1976. J Infect Dis. 1977;136(Suppl):S341-S742. Google Scholar15. GLEZEN W. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev. 1982;4:25-44. CrossrefMedlineGoogle Scholar16. GLEZENSIXFRANK WHA. Impact of epidemics upon communities and families. In: KENDAL AP, PATRIARCA PA, eds. Options for the control of influenza. New York: Alan R. Liss; 1986:63-73. Google Scholar17. HAMMONDCLEARY GM. Absenteeism among hospital staff during an influenza epidemic: implications for immunoprophylaxis. Can Med Assoc J. 1984;131:449-52. MedlineGoogle Scholar18. HORADAMSHARPSMILACKSCHONBERGER VJJL. Pharmacokinetics of amantadine hydrochloride in subjects with normal and impaired renal function. Ann Intern Med. 1981;94:454-8. LinkGoogle Scholar19. KAPLANKATONAHURWITZSCHONBERGER JPEL. GuillainBarré syndrome in the United States, 1979-1980 and 1980-1981. Lack of an association with influenza vaccination. JAMA. 1982;248:698-700. CrossrefMedlineGoogle Scholar20. KILBOURNE E ed. The influenza viruses and influenza. New York: Academic Press: 1975. Google Scholar21. LAMONTAGNENOBLEQUINNAN JGG. Summary of clinical trials of inactivated influenza vaccine-1978. Rev Infect Dis. 1983;5:723-36. CrossrefMedlineGoogle Scholar22. MUFSONKRAUSETARRANTSCHIFFMANCANO MHCGF. Polyvalent pneumococcal vaccine given alone and in combination with bivalent influenza vaccine. Proc Soc Exp Biol Med. 1980;163:498-503. CrossrefMedlineGoogle Scholar23. NOLANGOODMANHINMANNOBLEKENDALTHACKER TRAGAS. Morbidity and mortality associated with influenza B in the United States, 1979-1980. A report from the Centers for Disease Control. J Infect Dis. 1980;142:360-2. CrossrefMedlineGoogle Scholar24. PATRIARCAKENDALSTRICOFWEBERMEISSNERDATENO PARJMB. Influenza vaccination and warfarin or theophylline toxicity in nursing home residents [Letter]. N Engl J Med. 1983;308:1601-2. CrossrefMedlineGoogle Scholar25. PATRIARCAWEBERPARKER PJR. Efficacy of influenza vaccine in nursing homes: reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA. 1985;253:1136-9. CrossrefMedlineGoogle Scholar26. PARKMANGALASSOTOPNOBLE PGFG. Summary of clinical trials of influenza vaccines. J Infect Dis. 1976;134:100-7. CrossrefGoogle Scholar27. WRIGHTDOLINLA PRM. Summary of clinical trials of influenza vaccines-II. J Infect Dis. 1976;134:633-8. CrossrefMedlineGoogle Scholar28. YOUNKINBETTSROTHDOUGLAS SRFR. Reduction in fever and symptoms in young adults with influenza A/Brazil/78 HlNl infection after treatment with aspirin or amantadine. Antimicrob Agents Chemother. 1983;23:577-82. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: ▸From the Immunization Practices Advisory Committee, Centers for Disease Control; Atlanta, Georgia. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byImproving influenza vaccination coverage at the University Medical Centre Ljubljana with workplace health promotion projectUnderstanding motivators and barriers of hospital-based obstetric and pediatric health care worker influenza vaccination programs in AustraliaA Surveillance System to Reduce Transmission of Pandemic H1N1 (2009) Influenza in a 2600-Bed Medical CenterImproving influenza vaccination rates in a large health serviceEffect of A Hospital Campaign for Influenza Vaccination of Healthcare WorkersInfluenza Vaccination of Healthcare Workers and Vaccine Allocation for Healthcare Workers During Vaccine ShortagesPreventing Nosocomial Influenza by Improving the Vaccine Acceptance Rate of CliniciansInfluenza in the acute hospital settingImmune Prophylaxis and VaccinationsCommunity-Acquired Pneumonia in Older PatientsRimantadine: A Clinical PerspectiveLack of compliance with influenza immunization for caretakers of neonatal intensive care unit patientsBiological Therapies in Geriatric PopulationsVaccination of the Dialysis PatientSafety and prophylactic efficacy of low-dose rimantadine in adults during an influenza A epidemicIntegrating residency training in geriatrics into existing outpatient curriculaInfluenza and AgingBarriers to influenza vaccine acceptance A survey of physicians and nursesDifferential effect of amantadine hydrochloride on the systemic and local immune response to influenza AEfficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza AAcute Respiratory Failure in PregnancyManagement of Pneumonia in OutpatientsDo hospital employees benefit from the influenza vaccine?Protective efficacy of low-dose amantadine in adults challenged with wild-type influenza A virusDiabetes mellitus in elderly patientsInfections in the Nursing Home 1 September 1986Volume 105, Issue 3Page: 399-404KeywordsAntiviralsAspirinChildrenProphylaxisVaccines Issue Published: 1 September 1986 PDF downloadLoading ...